These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 35532296)
1. LIMD2 promotes tumor proliferation, invasion, and epithelial-mesenchymal transition in clear cell renal cell carcinoma. Zhong QY; Xie YW; Chen ZL; Chen YQ; Liu YX; Xie WL; Yan W Neoplasma; 2022 Jul; 69(4):832-840. PubMed ID: 35532296 [TBL] [Abstract][Full Text] [Related]
2. IFI16 promotes the progression of clear cell renal cell carcinoma through the IL6/PI3K/AKT axis. Lu K; Zhao Y; Li Y; Fu Z; Chen Y; Kong Y; Li G J Transl Med; 2024 Jun; 22(1):533. PubMed ID: 38831470 [TBL] [Abstract][Full Text] [Related]
3. MTDH promotes metastasis of clear cell renal cell carcinoma by activating SND1-mediated ERK signaling and epithelial-mesenchymal transition. He A; He S; Huang C; Chen Z; Wu Y; Gong Y; Li X; Zhou L Aging (Albany NY); 2020 Jan; 12(2):1465-1487. PubMed ID: 31978894 [TBL] [Abstract][Full Text] [Related]
4. RP11-367G18.1 V2 enhances clear cell renal cell carcinoma progression via induction of epithelial-mesenchymal transition. Shao IH; Peng PH; Wu HH; Chen JL; Lai JC; Chang JS; Wu HT; Wu KJ; Pang ST; Hsu KW Cancer Med; 2023 Apr; 12(8):9788-9801. PubMed ID: 36847128 [TBL] [Abstract][Full Text] [Related]
5. ADAM12 promotes clear cell renal cell carcinoma progression and triggers EMT via EGFR/ERK signaling pathway. Xu J; Wang Y; Jiang J; Yin C; Shi B J Transl Med; 2023 Jan; 21(1):56. PubMed ID: 36717944 [TBL] [Abstract][Full Text] [Related]
6. Downregulation of NEBL promotes migration and invasion of clear cell renal cell carcinoma by inducing epithelial-mesenchymal transition. Zhao R; Liang Z; Chu J; Zheng Q; Zhao J; Tang S; Chen Q; Huang Y; Zhou X; Pan X Pathol Res Pract; 2024 Feb; 254():155068. PubMed ID: 38215565 [TBL] [Abstract][Full Text] [Related]
7. MIOX inhibits autophagy to regulate the ROS -driven inhibition of STAT3/c-Myc-mediated epithelial-mesenchymal transition in clear cell renal cell carcinoma. Meng L; Gao J; Mo W; Wang B; Shen H; Cao W; Ding M; Diao W; Chen W; Zhang Q; Shu J; Dai H; Guo H Redox Biol; 2023 Dec; 68():102956. PubMed ID: 37977044 [TBL] [Abstract][Full Text] [Related]
8. TAGLN2 Promotes the Proliferation, Migration, Invasion, and EMT of Clear Cell Renal Cell Carcinoma Through the PI3K/Akt Signaling Pathway. He Y; Zhang B; Han D; Du Y; Zhang X; Wang H; Yue Z; Shang P Biochem Genet; 2023 Aug; 61(4):1265-1281. PubMed ID: 36547768 [TBL] [Abstract][Full Text] [Related]
9. KDM6B induces epithelial-mesenchymal transition and enhances clear cell renal cell carcinoma metastasis through the activation of SLUG. Li Q; Hou L; Ding G; Li Y; Wang J; Qian B; Sun J; Wang Q Int J Clin Exp Pathol; 2015; 8(6):6334-44. PubMed ID: 26261509 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of epithelial-mesenchymal transition markers in clear cell renal cell carcinoma. Xu H; Xu WH; Ren F; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW Aging (Albany NY); 2020 Jan; 12(1):866-883. PubMed ID: 31915310 [TBL] [Abstract][Full Text] [Related]
11. Formin-related protein 1 facilitates proliferation and aggressive phenotype of clear cell renal cell carcinoma through MAPK/MMP2 pathway. Ma G; Zhang B; Fu S; Lu J; Zhang L; Shang P; Yue Z Mol Cell Probes; 2023 Oct; 71():101921. PubMed ID: 37454877 [TBL] [Abstract][Full Text] [Related]
12. Downregulation of FOXO3a promotes tumor metastasis and is associated with metastasis-free survival of patients with clear cell renal cell carcinoma. Ni D; Ma X; Li HZ; Gao Y; Li XT; Zhang Y; Ai Q; Zhang P; Song EL; Huang QB; Fan Y; Zhang X Clin Cancer Res; 2014 Apr; 20(7):1779-90. PubMed ID: 24486593 [TBL] [Abstract][Full Text] [Related]
13. GTSE1 promotes tumor growth and metastasis by attenuating of KLF4 expression in clear cell renal cell carcinoma. Chen W; Wang H; Lu Y; Huang Y; Xuan Y; Li X; Guo T; Wang C; Lai D; Wu S; Zhao W; Mai H; Li H; Wang B; Ma X; Zhang X Lab Invest; 2022 Sep; 102(9):1011-1022. PubMed ID: 35585131 [TBL] [Abstract][Full Text] [Related]
14. Hypoxia-induced overexpression of stanniocalcin-1 is associated with the metastasis of early stage clear cell renal cell carcinoma. Ma X; Gu L; Li H; Gao Y; Li X; Shen D; Gong H; Li S; Niu S; Zhang Y; Fan Y; Huang Q; Lyu X; Zhang X J Transl Med; 2015 Feb; 13():56. PubMed ID: 25740019 [TBL] [Abstract][Full Text] [Related]
15. TOX3 inhibits cancer cell migration and invasion via transcriptional regulation of SNAI1 and SNAI2 in clear cell renal cell carcinoma. Jiang B; Chen W; Qin H; Diao W; Li B; Cao W; Zhang Z; Qi W; Gao J; Chen M; Zhao X; Guo H Cancer Lett; 2019 May; 449():76-86. PubMed ID: 30772441 [TBL] [Abstract][Full Text] [Related]
16. Exosomal microRNA-15a from ACHN cells aggravates clear cell renal cell carcinoma via the BTG2/PI3K/AKT axis. Li DY; Lin FF; Li GP; Zeng FC Kaohsiung J Med Sci; 2021 Nov; 37(11):973-982. PubMed ID: 34337864 [TBL] [Abstract][Full Text] [Related]
17. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway. Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788 [TBL] [Abstract][Full Text] [Related]
18. Expression of apolipoprotein C1 in clear cell renal cell carcinoma: An oncogenic gene and a prognostic marker. Wang HJ; Ma YX; Wang AH; Jiang YS; Jiang XZ Kaohsiung J Med Sci; 2021 May; 37(5):419-426. PubMed ID: 33305507 [TBL] [Abstract][Full Text] [Related]
19. miR-19a correlates with poor prognosis of clear cell renal cell carcinoma patients via promoting cell proliferation and suppressing PTEN/SMAD4 expression. Ma Q; Peng Z; Wang L; Li Y; Wang K; Zheng J; Liang Z; Liu T Int J Oncol; 2016 Dec; 49(6):2589-2599. PubMed ID: 27779660 [TBL] [Abstract][Full Text] [Related]
20. CD103-positive CSC exosome promotes EMT of clear cell renal cell carcinoma: role of remote MiR-19b-3p. Wang L; Yang G; Zhao D; Wang J; Bai Y; Peng Q; Wang H; Fang R; Chen G; Wang Z; Wang K; Li G; Yang Y; Wang Z; Guo P; Peng L; Hou D; Xu W Mol Cancer; 2019 Apr; 18(1):86. PubMed ID: 30975145 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]